Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities

A Pocivavsek, R Schwarcz… - Pharmacological …, 2024 - pharmrev.aspetjournals.org
Both preclinical and clinical studies implicate functional impairments of several neuroactive
metabolites of the kynurenine pathway (KP), the major degradative cascade of the essential …

Neuroendocrine control of hyperglutamatergic states in brain pathologies: the effects of glucocorticoids

NV Gulyaeva - Journal of Evolutionary Biochemistry and Physiology, 2022 - Springer
Neuroendocrine control mediated by glucocorticoids is important for maintaining the normal
functioning of the brain and the balance between the excitation and inhibition systems …

ROS/electro dual-reactive nanogel for targeting epileptic foci to remodel aberrant circuits and inflammatory microenvironment

Z Zhou, K Li, Y Guo, P Liu, Q Chen, H Fan, T Sun… - ACS …, 2023 - ACS Publications
Medicinal treatment against epilepsy is faced with intractable problems, especially
epileptogenesis that cannot be blocked by clinical antiepileptic drugs (AEDs) during the …

The role of the gut-microbiome-brain axis in metabolic remodeling amongst children with cerebral palsy and epilepsy

Y Peng, ATG Chiu, VWY Li, X Zhang, WL Yeung… - Frontiers in …, 2023 - frontiersin.org
Background Epilepsy-associated dysbiosis in gut microbiota has been previously described,
but the mechanistic roles of the gut microbiome in epileptogenesis among children with …

Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: A biomarker of response to corticosteroids

J Yan, K Kothur, EA Innes, VX Han, HF Jones… - …, 2022 - thelancet.com
Background Epileptic (previously infantile) spasms is the most common epileptic
encephalopathy occurring during infancy and is frequently associated with abnormal …

Cellular localization of kynurenine 3-monooxygenase in the brain: Challenging the dogma

KV Sathyasaikumar, V Pérez de la Cruz, B Pineda… - Antioxidants, 2022 - mdpi.com
Kynurenine 3-monooxygenase (KMO), a key player in the kynurenine pathway (KP) of
tryptophan degradation, regulates the synthesis of the neuroactive metabolites 3 …

Differential glutamate receptor expression and function in the hippocampus, anterior temporal lobe and neocortex in a pilocarpine model of temporal lobe epilepsy

V Dubey, S Dey, AB Dixit, M Tripathi, PS Chandra… - Experimental …, 2022 - Elsevier
Temporal lobe epilepsy (TLE) is the most common form of intractable epilepsy where
hyperactive glutamate receptors may contribute to the complex epileptogenic network hubs …

Differential levels of tryptophan–kynurenine pathway metabolites in the hippocampus, anterior temporal lobe, and neocortex in an animal model of temporal lobe …

S Dey, V Dubey, AB Dixit, M Tripathi, PS Chandra… - Cells, 2022 - mdpi.com
Glutamate-receptor-mediated hyperexcitability contributes to seizure generation in temporal
lobe epilepsy (TLE). Tryptophan–kynurenine pathway (TKP) metabolites regulate glutamate …

Ameliorative effect of diclofenac in rotenone corneal kindling model of drug-resistant epilepsy: Edge of dual COX and KMO inhibition

A Kaur, A Kaur, RK Goel - Brain Research, 2025 - Elsevier
Epilepsy affects millions of people worldwide, about one-third patients with epilepsy exhibits
resistance to available antiseizures medications, known as drug-resistant epilepsy (DRE) …

Novel variants in GABAA receptor subunits: A possible association with benzodiazepine resistance in patients with drug-resistant epilepsy

A Chakraborty, S Dey, K Kumar, AB Dixit, M Tripathi… - Epilepsy Research, 2023 - Elsevier
Benzodiazepines (BDZ) such as diazepam and lorazepam are popular as first-line treatment
for acute seizures due to their rapid action and high efficacy. However, long-term usage of …